Search results
Feb 11, 2021 · The proportion correctly wearing masks indoors varied by mask type, from 96.8% for N95-type masks and 92.2% for cloth masks to 78.9% for bandanas, scarves, and similar face coverings. Observed indoor mask use was high at these six universities with mask mandates.
- Lisa C Barrios, Margaret A Riggs, Ridgely Fisk Green, Michaila Czarnik, Randall J Nett, J Erin Stapl...
- 2021
Feb 25, 2021 · Statewide mask mandates might be associated with reductions in SARS-CoV-2 transmission and might contribute to reductions in COVID-19 hospitalization growth rates, compared with growth rates during <4 weeks before implementation of the mandate and the implementation week.
- Heesoo Joo, Gabrielle F. Miller, Gregory Sunshine, Maxim Gakh, Jamison Pike, Fiona P. Havers, Lindsa...
- 2021
People also ask
Do statewide mask mandates increase hospitalization rates?
Why do people wear face masks?
Should mask-wearing behaviour be taught?
Does mask use vary over time?
Dec 6, 2021 · The community benefit of masking for SARS-CoV-2 control is due to the combination of these two effects (source control and filtration for wearer protection); individual prevention benefit increases with increasing numbers of people using masks consistently and correctly.
May 11, 2023 · Wearing a highly protective mask or respirator may be most important for certain higher risk situations, or by some people at increased risk for severe disease. CDC’s mask recommendations provide information that people can use to improve how well their masks protect them.
May 23, 2022 · None-the-less, the ratio of incident risk for masked vs. non-masked populations still shows a benefit of wearing masks even with the higher R0 variants. Similar content being viewed by...
Mar 3, 2022 · The new metrics raise case thresholds for wearing masks and other precautions to 200 weekly cases per 100,000 people. Below that level of cases is now considered low risk, as long as the number...
Jan 19, 2021 · The effect of mask-wearing on community transmission of SARS-CoV-2 has been the subject of substantial debate, despite evidence of its potential effect to reduce SARS-CoV-2 spread from detailed transmission studies and population-wide data from other respiratory pathogens.
